Melatonin rhythmicity: Effect of age and Alzheimer's disease

Experimental Gerontology

Volumn 38, Issue 1-2, 2003, Pages 199-206

  Skene, Debra J ^a   Swaab, Dick F ^b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Aging; Alzheimer's disease; Circadian clock; Circadian rhythms; Light therapy; Melatonin; Pineal gland; Suprachiasmatic nuclei

Indexed keywords

HALOPERIDOL; HYPNOTIC AGENT; MELATONIN; NEUROLEPTIC AGENT;

AGE; ALZHEIMER DISEASE; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CONFERENCE PAPER; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; NERVE TRACT; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PINEAL BODY; PINEAL GLAND FUNCTION; PRIORITY JOURNAL; RETINA; RETINA MACULOPATHY; SLEEP WAKING CYCLE; SUPRACHIASMATIC NUCLEUS; VISUAL DISORDER; WHITE LIGHT;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MELATONIN; MENTAL DISORDERS; PHOTOTHERAPY; PINEAL GLAND; SECRETORY RATE; SLEEP DISORDERS; SUPRACHIASMATIC NUCLEUS;

EID: 0037244324     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(02)00198-5     Document Type: Conference Paper

References (98)

1. Ancoli-Israel S., Klauber M.R., Jones D.W., Kripke D.F., Martin J., Mason W., Pat-Horenczyk R., Fell R. Variations in circadian rhythms of activity, sleep, and light exposure related to dementia in nursing-home patients. Sleep. 20:1997;18-23.
2. Arendt J. Melatonin and the Mammalian Pineal Gland. 1995;Chapman and Hall, London.
3. Blanks J.C., Hinton D.R., Sadun A.A., Miller C.A. Retinal ganglion cell degeneration in Alzheimer's disease. Brain Res. 501:1989;364-372.
4. Blanks J.C., Schmidt S.Y., Torigoe Y., Porrello K.V., Hinton D.R., Blanks R.H. Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol. Aging. 17:1996;385-395.
5. Blanks J.C., Torigoe Y., Hinton D.R., Blanks R.H. Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol. Aging. 17:1996;377-384.
6. Bliwise D.L., Hughes M., McMahon P.M., Kutner N. Observed sleep/wakefulness and severity of dementia in an Alzheimer's disease special care unit. J Gerontol. A Biol. Sci. Med. Sci. 50:1995;M303-M306.
7. Bojkowski C.J., Arendt J. Factors influencing urinary 6-sulphatoxymelatonin, a major melatonin metabolite, in normal human subjects. Clin. Endocrinol. (Oxf). 33:1990;435-444.
8. Brainard G.C., Hanifin J.P., Greeson J.M., Byrne B., Glickman G., Gerner E., Rollag M.D. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J. Neurosci. 21:2001;6405-6412.
9. Brusco L.I., Fainstein I., Marquez M., Cardinali D.P. Effect of melatonin in selected populations of sleep-disturbed patients. Biol. Signals Recept. 8:1999;126-131.
10. Brusco L.I., Marquez M., Cardinali D.P. Monozygotic twins with Alzheimer's disease treated with melatonin: case report. J. Pineal Res. 25:1998;260-263.
11. Burney-Puckett M. Sundown syndrome: etiology and management. J. Psychosoc. Nurs. Ment. Health Serv. 34:1996;40-43.
12. Campbell S.S., Kripke D.F., Gillin J.C., Hrubovcak J.C. Exposure to light in healthy elderly subjects and Alzheimer's patients. Physiol. Behav. 42:1988;141-144.
13. Campbell S.S., Terman M., Lewy A.J., Dijk D.J., Eastman C.I., Boulos Z. Light treatment for sleep disorders: consensus report. V. Age-related disturbances. J. Biol. Rhythms. 10:1995;151-154.
14. Carrier J., Monk T.H., Buysse D.J., Kupfer D.J. Amplitude reduction of the circadian temperature and sleep rhythms in the elderly. Chronobiol. Int. 13:1996;373-386.
15. Cohen-Mansfield J., Garfinkel D., Lipson S. Melatonin for treatment of sundowning in elderly persons with dementia - a preliminary study. Arch. Gerontol. Geriatr. 31:2000;65-76.
16. Colenda C.C., Cohen W., McCall W.V., Rosenquist P.B. Phototherapy for patients with Alzheimer disease with disturbed sleep patterns: results of a community-based pilot study. Alzheimer Dis. Assoc. Disord. 11:1997;175-178.
17. Cornelissen G., Halberg F., Burioka N., Perfetto F., Tarquini R., Bakken E.E. Do plasma melatonin concentrations decline with age? Am. J. Med. 109:2000;343-345.
18. Cugini P., Kawasaki T., Lucia P., Leone G., Pelosio A., Uezono K. Age-related changes in blood pressure twenty-four-hour pattern in normotensive subjects of two populations. Clin. Ther. 150:1999;21-27.
19. Curcio C.A., Drucker D.N. Retinal ganglion cells in Alzheimer's disease and aging. Ann. Neurol. 33:1993;248-257.
20. Czeisler C.A., Duffy J.F., Shanahan T.L., Brown E.N., Mitchell J.F., Rimmer D.W., Ronda J.M., Silva E.J., Allan J.S., Emens J.S., Dijk D.J., Kronauer R.E. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science. 284:1999;2177-2181.
21. Daniels W.M., van Rensburg S.J., van Zyl J.M., Taljaard J.J. Melatonin prevents beta-amyloid-induced lipid peroxidation. J. Pineal Res. 24:1998;78-82.
22. Davies D.C., McCoubrie P., McDonald B., Jobst K.A. Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease. Brain J. Ophthalmol. 79:1995;596-600.
23. Deacon S., English J., Arendt J. Acute phase-shifting effects of melatonin associated with suppression of core body temperature in humans. Neurosci. Lett. 178:1994;32-34.
24. Dijk D.J., Duffy J.F., Czeisler C.A. Contribution of circadian physiology and sleep homeostasis to age-related changes in human sleep. Chronobiol. Int. 17:2000;285-311.
25. Dowling G.A. Behavioral intervention strategies for sleep-activity disruption. Int. Psychogeriatr. 8:(suppl. 1):1996;77-86.
26. Duffy J.F., Dijk D.J., Klerman E.B., Czeisler C.A. Later endogenous circadian temperature nadir relative to an earlier wake time in older people. Am. J. Physiol. 275:1998;R1478-R1487.
27. Ferrari E., Arcaini A., Gornati R., Pelanconi L., Cravello L., Fioravanti M., Solerte S.B., Magri F. Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia. Exp. Gerontol. 35:2000;1239-1250.
28. Fourtillan J.B., Brisson A.M., Fourtillan M., Ingrand I., Decourt J.P., Girault J. Melatonin secretion occurs at a constant rate in both young and older men and women. Am. J. Physiol. Endocrinol. Metab. 280:2001;E11-E22.
29. Harper D.G., Stopa E.G., McKee A.C., Satlin A., Harlan P.C., Goldstein R., Volicer L. Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Arch. Gen. Psychiatry. 58:2001;353-360.
30. Hedges T.R. III, Perez Galves R., Speigelman D., Barbas N.R., Peli E., Yardley C.J. Retinal nerve fiber layer abnormalities in Alzheimer's disease. Acta Ophthalmol. Scand. 74:1996;271-275.
31. Hinton D.R., Sadun A.A., Blanks J.C., Miller C.A. Optic-nerve degeneration in Alzheimer's disease. N. Engl. J. Med. 315:1986;485-487.
32. Hofman M.A., Swaab D.F. Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res. 651:1994;134-142.
33. Hofman M.A., Swaab D.F. Influence of aging on the seasonal rhythm of the vasopressin-expressing neurons in the human suprachiasmatic nucleus. Neurobiol. Aging. 16:1995;965-971.
34. Humbert W., Pevet P. Calcium content and concretions of pineal glands of young and old rats. A scanning and X-ray microanalytical study. Cell Tissue Res. 263:1991;593-596.
35. Iguichi H., Kato K.I., Ibayashi H. Age-dependent reduction in serum melatonin concentrations in healthy human subjects. J. Clin. Endocrinol. Metab. 55:1982;27-29.
36. Justino L., Kergoat M., Bergman H., Chertkow H., Robillard A., Kergoat H. Neuroretinal function is normal in early dementia of the Alzheimer type. Neurobiol. Aging. 22:2001;691-695.
37. Katz B., Rimmer S., Iragui V., Katzman R. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration? Ann. Neurol. 26:1989;221-225.
38. Kendall A.R., Lewy A.J., Sack R.L. Effects of aging on the intrinsic circadian period of totally blind humans. J. Biol. Rhythms. 16:2001;87-95.
39. Kennaway D.J., Lushington K., Dawson D., Lack L., van den Heuvel C., Rogers N. Urinary 6-sulfatoxymelatonin excretion and aging: new results and a critical review of the literature. J. Pineal Res. 27:1999;210-220.
40. Kergoat H., Kergoat M.J., Justino L., Chertkow H., Robillard A., Bergman H. An evaluation of the retinal nerve fiber layer thickness by scanning laser polarimetry in individuals with dementia of the Alzheimer type. Acta Ophthalmol. Scand. 79:2001;187-191.
41. Klaver C.C., Ott A., Hofman A., Assink J.J., Breteler M.M., de Jong P.T. Is age-related maculopathy associated with Alzheimer's Disease? the Rotterdam Study. Am. J. Epidemiol. 150:1999;963-968.
42. Klerman E.B., Duffy J.F., Dijk D.J., Czeisler C.A. Circadian phase resetting in older people by ocular bright light exposure. J. Investig. Med. 49:2001;30-40.
43. Kunz D., Schmitz S., Mahlberg R., Mohr A., Stoter C., Wolf K.J., Herrmann W.M. A new concept for melatonin deficit: on pineal calcification and melatonin excretion. Neuropsychopharmacology. 21:1999;765-772.
44. Lebert F., Pasquier F., Petit H. Sundowning syndrome in demented patients without neuroleptic therapy. Arch. Gerontol. Geriatr. 22:1996;49-54.
45. Liu R.Y., Zhou J.N., van Heerikhuize J., Hofman M.A., Swaab D.F. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J. Clin. Endocrinol. Metab. 84:1999;323-327.
46. Liu R.Y., Zhou J.N., Hoogendijk W.J., van Heerikhuize J., Kamphorst W., Unmehopa U.A., Hofman M.A., Swaab D.F. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J. Neuropathol. Exp. Neurol. 59:2000;314-322.
47. Lockley S.W., Skene D.J., Arendt J., Tabandeh H., Bird A.C., Defrance R. Relationship between melatonin rhythms and visual loss in the blind. J. Clin. Endocrinol. Metab. 82:1997;3763-3770.
48. Lockley S.W., Skene D.J., Tabandeh H., Bird A.C., Defrance R., Arendt J. Relationship between napping and melatonin in the blind. J. Biol. Rhythms. 12:1997;16-25.
49. Luboshitzky R., Yanai D., Shen-Orr Z., Israeli E., Herer P., Lavie P. Daily and seasonal variations in the concentration of melatonin in the human pineal gland. Brain Res. Bull. 47:1998;271-276.
50. Lucassen P.J., Hofman M.A., Swaab D.F. Increased light intensity prevents the age related loss of vasopressin-expressing neurons in the rat suprachiasmatic nucleus. Brain Res. 693:1995;261-266.
51. Lutze M., Bresnick G.H. Lenses of diabetic patients yellow at an accelerated rate similar to older normals. Investig. Ophthalmol. Vis. Sci. 32:1991;194-199.
52. Magri F., Locatelli M., Balza G., Molla G., Cuzzoni G., Fioravanti M., Solerte S.B., Ferrari E. Changes in endocrine circadian rhythms as markers of physiological and pathological brain aging. Chronobiol. Int. 14:1997;385-396.
53. Meisami F. Aging of the nervous system: sensory changes. Timiras P.S. Physiological Basis of Geriatrics. 1988;156-178 MacMillan, New York.
54. Mirmiran M., Swaab D.F., Kok J.H., Hofman M.A., Witting W., Van Gool W.A. Circadian rhythms and the suprachiasmatic nucleus in perinatal development, aging and Alzheimer's disease. Prog. Brain Res. 93:1992;151-162. discussion, 162-163.
55. Mishima K., Okawa M., Hishikawa Y., Hozumi S., Hori H., Takahashi K. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr. Scand. 89:1994;1-7.
56. Mishima K., Okawa M., Satoh K., Shimizu T., Hozumi S., Hishikawa Y. Different manifestations of circadian rhythms in senile dementia of Alzheimer's type and multi-infarct dementia. Neurobiol. Aging. 18:1997;105-109.
57. Mishima K., Tozawa T., Satoh K., Matsumoto Y., Hishikawa Y., Okawa M. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking. Biol. Psychiatry. 45:1999;417-421.
58. Mishima K., Okawa M., Shimizu T., Hishikawa Y. Diminished melatonin secretion in the elderly caused by insufficient environmental illumination. J. Clin. Endocrinol. Metab. 86:2001;129-134.
59. Moe K.E., Vitiello M.V., Larsen L.H., Prinz P.N. Symposium: cognitive processes and sleep disturbances: sleep/wake patterns in Alzheimer's disease: relationships with cognition and function. J. Sleep Res. 4:1995;15-20.
60. Myers B.L., Badia P. Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neurosci. Biobehav. Rev. 19:1995;553-571.
61. van de Nes J.A., Kamphorst W., Ravid R., Swaab D.F. Comparison of beta-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently. Acta Neuropathol. (Berl). 96:1998;129-138.
62. Ohashi Y., Okamoto N., Uchida K., Iyo M., Mori N., Morita Y. Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type. Biol. Psychiatry. 45:1999;1646-1652.
63. Ouslander J.G., Buxton W.G., Al-Samarrai N.R., Cruise P.A., Alessi C., Schnelle J.F. Nighttime urinary incontinence and sleep disruption among nursing home residents. J. Am. Geriatr. Soc. 46:1998;463-466.
64. Pappolla M.A., Sos M., Omar R.A., Bick R.J., Hickson-Bick D.L., Reiter R.J., Efthimiopoulos S., Robakis N.K. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci. 17:1997;1683-1690.
65. Pappolla M., Bozner P., Soto C., Shao H., Robakis N.K., Zagorski M., Frangione B., Ghiso J. Inhibition of Alzheimer beta-fibrillogenesis by melatonin. J. Biol. Chem. 273:1998;7185-7188.
66. Pappolla M.A., Chyan Y.J., Poeggeler B., Frangione B., Wilson G., Ghiso J., Reiter R.J. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J. Neural Transm. 107:2000;203-231.
67. Pardo C.A., Martin L.J., Troncoso J.C., Price D.L. The human pineal gland in aging and Alzheimer's disease: patterns of cytoskeletal antigen immunoreactivity. Acta Neuropathol. (Berl). 80:1990;535-540.
68. Pollak C.P., Perlick D. Sleep problems and institutionalization of the elderly. J. Geriatr. Psychiatry Neurol. 4:1991;204-210.
69. Prinz P.N., Christie C., Smallwood R., Vitaliano P., Bokan J., Vitiello M.V., Martin D. Circadian temperature variation in healthy aged and in Alzheimer's disease. J. Gerontol. 39:1984;30-35.
70. Puig-Domingo M., Webb S.M., Serrano J., Peinado M.A., Corcoy R., Ruscalleda J., Reiter R.J., de Leiva A. Brief report: melatonin-related hypogonadotropic hypogonadism. N. Engl. J. Med. 327:1992;1356-1359.
71. Reiter R.J., Tan D.X., Osuna C., Gitto E. Actions of melatonin in the reduction of oxidative stress. A review. J. Biomed. Sci. 7:2000;444-458.
72. Sack R.L., Lewy A.J., Erb D.L., Vollmer W.M., Singer C.M. Human melatonin production decreases with age. J. Pineal Res. 3:1986;379-388.
73. Satlin A., Volicer L., Ross V., Herz L., Campbell S. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. Am. J. Psychiatry. 149:1992;1028-1032.
74. Shochat T., Martin J., Marler M., Ancoli-Israel S. Illumination levels in nursing home patients: effects on sleep and activity rhythms. J. Sleep Res. 9:2000;373-379.
75. Skene D.J., Bojkowski C.J., Currie J.E., Wright J., Boulter P.S., Arendt J. 6-sulphatoxymelatonin production in breast cancer patients. J. Pineal Res. 8:1990;269-276.
76. Skene D.J., Vivien-Roels B., Sparks D.L., Hunsaker J.C., Pevet P., Ravid D., Swaab D.F. Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Res. 528:1990;170-174.
77. Skene D.J., Lockley S.W., James K., Arendt J. Correlation between urinary cortisol and 6-sulphatoxymelatonin rhythms in field studies of blind subjects. Clin. Endocrinol. (Oxf). 50:1999;715-719.
78. Song W., Lahiri D.K. Melatonin alters the metabolism of the beta-amyloid precursor protein in the neuroendocrine cell line PC12. J. Mol. Neurosci. 9:1997;75-92.
79. Stopa E.G., Volicer L., Kuo-Leblanc V., Harper D., Lathi D., Tate B., Satlin A. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J. Neuropathol. Exp. Neurol. 58:1999;29-39.
80. Suzuki S., Horiguchi M., Tanikawa A., Miyake Y., Kondo M. Effect of age on short-wavelength sensitive cone electroretinogram and long- and middle-wavelength sensitive cone electroretinogram. Jpn J. Ophthalmol. 42:1998;424-430.
81. Swaab D.F., Fliers E., Partiman T.S. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res. 342:1985;37-44.
82. Swaab D.F., Roozendaal B., Ravid R., Velis D.N., Gooren L., Williams R.S. Suprachiasmatic nucleus in aging, Alzheimer's disease, transsexuality and Prader-Willi syndrome. Prog. Brain Res. 72:1987;301-310.
83. Tan D.X., Manchester L.C., Reiter R.J., Plummer B.F., Limson J., Weintraub S.T., Qi W. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic. Biol. Med. 29:2000;1177-1185.
84. Thapan K., Arendt J., Skene D.J. An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J. Physiol. 535:2001;261-267.
85. Touitou Y., Bogdan A., Haus E., Touitou C. Modifications of circadian and circannual rhythms with aging. Exp. Gerontol. 32:1997;603-614.
86. Trick G.L., Barris M.C., Bickler-Bluth M. Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type. Ann. Neurol. 26:1989;226-231.
87. Uchida K., Okamoto N., Ohara K., Morita Y. Daily rhythm of serum melatonin in patients with dementia of the degenerate type. Brain Res. 717:1996;154-159.
88. Van Someren E.J., Mirmiran M., Swaab D.F. Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer's disease: chronobiological perspectives. Behav. Brain Res. 57:1993;235-253.
89. Van Someren E.J., Kessler A., Mirmiran M., Swaab D.F. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol. Psychiatry. 41:1997;955-963.
90. Van Someren E.J., Swaab D.F., Colenda C.C., Cohen W., McCall W.V., Rosenquist P.B. Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol. Int. 16:1999;505-518.
91. Volicer L., Harper D.G., Manning B.C., Goldstein R., Satlin A. Sundowning and circadian rhythms in Alzheimer's disease. Am. J. Psychiatry. 158:2001;704-711.
92. Waldhauser F., Weiszenbacher G., Tatzer E., Gisinger B., Waldhauser M., Schemper M., Frisch H. Alterations in nocturnal serum melatonin levels in humans with growth and aging. J. Clin. Endocrinol. Metab. 66:1988;648-652.
93. Weitzman E.D., Moline M.L., Czeisler C.A., Zimmerman J.C. Chronobiology of aging: temperature, sleep-wake rhythms and entrainment. Neurobiol. Aging. 3:1982;299-309.
94. Wirz-Justice A., Werth E., Savaskan E., Knoblauch V., Gasio P.F., Muller-Spahn F. Haloperidol disrupts, clozapine reinstates the circadian rest-activity cycle in a patient with early-onset Alzheimer disease. Alzheimer Dis. Assoc. Disord. 14:2000;212-215.
95. Witting W., Kwa I.H., Eikelenboom P., Mirmiran M., Swaab D.F. Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol. Psychiatry. 27:1990;563-572.
96. Yamadera H., Ito T., Suzuki H., Asayama K., Ito R., Endo S. Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psychiatry Clin. Neurosci. 54:2000;352-353.
97. Young I.M., Francis P.L., Leone A.M., Stovell P., Silman R.E. Constant pineal output and increasing body mass account for declining melatonin levels during human growth and sexual maturation. J. Pineal Res. 5:1988;71-85.
98. Zeitzer J.M., Daniels J.E., Duffy J.F., Klerman E.B., Shanahan T.L., Dijk D.J., Czeisler C.A. Do plasma melatonin concentrations decline with age? Am. J. Med. 107:1999;432-436.